Discover our new webpage dedicated to 90 years of HA
and download our White paper now!
Press releases
June 3, 2024
BIOPHTA 6.5 million Euros Seed Funding
Paris, June 3, 2024
BIOPHTA, a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, has just closed a € 6.5 million Seed round to bring its patented technology to clinical development.
This funding round was led by leading European VCs – UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners), Elaia and GO Capital – as well as one major ophthalmology player, Unither Pharmaceuticals and HTL Biotechnology, the global leader in production and development of pharma grade biopolymers.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles November 14, 2024Discover our new webpage dedicated to 90 years of HA and download our White Paper!
and download our White paper now!
-
Articles October 8, 2024HTL Biotechnology at CPHI Milano
As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.
-
Articles October 4, 20241st symposium for HTL Biotechnology at MAIS congress
As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.